Results 181 to 190 of about 173,132 (261)

Strategies for enhancing sensitivity in lateral flow assays

VIEW, EarlyView.
Lateral flow assays (LFAs) are essential for cost‐effective, rapid point‐of‐care diagnostics. However, conventional colourimetric LFAs often lack the sensitivity required for low‐abundance biomarkers. This review evaluates six enhancement strategies: flow modulation, sample preconcentration, advanced reporters, chemical signal amplification, structural
Aylar Eslami Saed, Jacopo Giaretta, Syamak Farajikhah, Fariba Dehghani   +3 more
wiley   +1 more source

Successful 6-year follow-up of treatment for IgA nephropathy complicated by IgA-λ monoclonal gammopathy with multi-system damage: a case report. [PDF]

Front Immunol
Li Y, Li X, Lu Y, Huang M.
europepmc   +1 more source

Real‐World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Background Tapinarof cream 1%, a non‐steroidal topical aryl hydrocarbon receptor‐modulating agent, is approved in Japan for atopic dermatitis (AD) and plaque psoriasis. Real‐world data on longitudinal outcomes, treatment continuation, interruption and restart, and adverse‐event timing are limited. Methods This single‐center retrospective study
Kanade Iino, Saori Takamura, Tomoo Fukuda   +2 more
wiley   +1 more source

Systemic Treatment of Psoriasis: Current Evidence on Efficacy and Safety

The Journal of Dermatology, EarlyView.
ABSTRACT Systemic treatments for moderate‐to‐severe plaque psoriasis have been advanced from broad immunosuppressants up to agents more selectively targeting cytokines, cytokine receptors, or intracellular signaling. The current systemic treatments mainly consist of conventional systemic agents, biologics targeting tumor necrosis factor (TNF)‐α ...
Teppei Hagino, Naoko Kanda
wiley   +1 more source

IgA Dominant Infection Related Glomerulonephritis Mimicking Primary IgA Nephropathy in Methicillin-Sensitive <i>Staphylococcus aureus</i> Osteomyelitis. [PDF]

Int J Nephrol Renovasc Dis
Klor B, Acharya PC, Cunningham I, Jaros A, Dass B.   +4 more
europepmc   +1 more source

Edges as ecological filters: Asymmetrical orientation‐specific arthropod activity across forest boundaries

Insect Science, EarlyView.
Moderate retention forestry creates structurally sharp forest edges that act as ecological filters, shaping orientation‐specific activity of ground‐dwelling arthropods. Using drift‐fence pitfall traps, we show that activity aligned with ecotones is more frequent than activity across forest–clearcut boundaries, particularly among detritivores.
Dominik Stočes, Ondřej Košulič, Adrián Purkart, Jan Šipoš   +3 more
wiley   +1 more source

Development of IgA nephropathy following risankizumab therapy for psoriatic arthritis: a case report. [PDF]

CEN Case Rep
Yagasaki M, Yamada K, Koshida T, Takagi M, Saeki H, Ogiwara K, Kobayashi T, Kihara M, Gohda T, Suzuki Y.   +9 more
europepmc   +1 more source

How do supermarkets shape the experience of vulnerable people in Australia's food system? A scoping review

Nutrition &Dietetics, EarlyView.
Abstract Aims The aim of this scoping review was to synthesise how supermarkets shape health behaviours and nutrition‐related outcomes of vulnerable populations in Australia. Methods Five databases were searched and studies were included if they discussed Australia's major supermarket chains, their relationship with vulnerable populations, and outcomes
Casey E. Webb, Jeremy Farr, Nathan Cook, Olivia R. L. Wright   +3 more
wiley   +1 more source

Cross-sectional Study of Dermatitis Herpetiformis with Focus on Neurological Comorbidities. [PDF]

Acta Derm Venereol
Malkovics T, Csák Z, Sodbuyan E, Lambertus I, Kárpáti S, Sárdy M.   +5 more
europepmc   +1 more source

Real‐World Retrospective Analysis of Daratumumab for Relapsed or Refractory Multiple Myeloma in Regional Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This retrospective case series evaluated all patients treated with daratumumab between 2018 and 2023 across two regional hospitals in Australia. Fifty‐two patients were included with a median age of 74. Median progression‐free survival (PFS) was 13 months and overall survival (OS) was 27 months, with an overall response rate was 35%.
Benjamin Reardon, Ian Kerridge, Tasman Armytage   +2 more
wiley   +1 more source